Polio laboratory findings: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(16 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Polio}}
{{Polio}}
{{CMG}}
{{CMG}}; {{AE}} {{JS}}


==Overview==
==Overview==
A laboratory diagnosis of poliomyelitis is usually made based on recovery of poliovirus from the stool or pharynx. Neutralizing antibodies to poliovirus can be diagnostic and are generally detected in the blood of infected patients early in the course of infection. Analysis of the patient's [[cerebrospinal fluid]] (CSF), which is collected by a [[lumbar puncture]] ("spinal tap") reveals an increased number of white blood cells (primarily lymphocytes) and a mildly elevated protein level. Detection of virus from the CSF is diagnostic of paralytic polio, but rarely occurs.
[[Poliovirus]] may be isolated from [[pharyngeal]] secretions during the first week of the disease, and from feces during several weeks. Isolation of [[poliovirus|virus]] from the [[cerebrospinal fluid]] ([[CSF]]) is diagnostic, however this is rarely accomplished.  Following isolation, the [[serotype]] and origin of the virus may be characterized by [[genomic]] sequencing.  The [[CSF]] may show unspecific findings of [[aseptic meningitis]], which are common to those found in [[infections]] by other [[virus]]es. When the virus cannot be isolated, [[serologic]] tests, using [[antibodies]] targeted to the 3 different [[serotype]]s may be used.<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref><ref name="mand">{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


== Laboratory Findings ==
== Laboratory Findings ==
===Viral Isolation===
===Viral Isolation===
Poliovirus may be recovered from the stool or pharynx of a person with poliomyelitis. Isolation of virus from the cerebrospinal fluid (CSF) is diagnostic, but is rarely accomplished. If poliovirus is isolated from a person with acute [[flaccid paralysis]], it must be tested further, using oligonucleotide mapping (fingerprinting) or genomic sequencing, to determine if the virus is “wild type” (that is, the virus that causes polio disease) or vaccine type (virus that could derive from a vaccine strain).
If [[poliovirus]] is isolated from a person with acute [[flaccid paralysis]], or if it occurs in an area where there is low [[incidence]] of the disease, it must be further tested in order to assess the source of the virus.  The virus may be "wild-type" (occurs naturally) or vaccine related (OPV).<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref><ref name="mand">{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>  The characterization of the source of the virus may be achieved by [[genomic]] sequencing.<ref name="KewMulders1995">{{cite journal|last1=Kew|first1=Olen M.|last2=Mulders|first2=Mick N.|last3=Lipskaya|first3=Galina Yu.|last4=da Silva|first4=Edson E.|last5=Patlansch|first5=Mark A.|title=Molecular epidemiology of polioviruses|journal=Seminars in Virology|volume=6|issue=6|year=1995|pages=401–414|issn=10445773|doi=10.1016/S1044-5773(05)80017-4}}</ref><ref name="mand">{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


===Serology===
===Cerebrospinal Fluid===
Neutralizing antibodies appear early and may be at high levels by the time the patient is hospitalized; therefore, a fourfold rise in antibody titer may not be demonstrated.
In [[poliovirus infection]], the [[CSF]] usually contains an increased number of [[white blood cell]]s (10–200 cells/mm3, primarily [[lymphocytes]]) and mildly elevated [[protein]] (40–50 mg/100 mL).<ref name=CDC>{{cite web | title = Poliomyelitis | url = http://www.cdc.gov/vaccines/pubs/pinkbook/polio.html#epi }}</ref>  However, these findings are similar to those of [[aseptic meningitis]] caused by other viruses.


===Cerebrospinal Fluid===
The isolation of [[poliovirus]] from the [[CSF]] is particularly important in cases of [[paralytic]] poliomyelitis following administration of the [[vaccine]].  Since viral shedding in feces occurs during several weeks after the person has been [[vaccinated]], isolation of the virus in the [[CNS]], and its characterization as "wild-type" or "vaccine related", is the only way of proving an association between the disease and the [[vaccine]].<ref name="mand">{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>
In poliovirus infection, the CSF usually contains an increased number of white blood cells (10–200 cells/mm3,
primarily lymphocytes) and a mildly elevated protein (40–50 mg/100 mL).


===PCR===
===Serology===
If poliovirus is isolated from a patient experiencing acute flaccid paralysis it is further tested, using oligonucleotide mapping (genetic fingerprinting), or more recently by PCR amplification, to determine if the virus is “wild type” (that is, the virus encountered in nature) or vaccine type (is derived from a strain of poliovirus used to produce polio vaccine). For each reported case of paralytic polio caused by wild poliovirus, it is estimated that another 200 to 3,000 contagious asymptomatic carriers exist. Therefore, isolation of wild poliovirus constitutes a public health emergency, and appropriate efforts to control the spread of the disease must be initiated immediately.
If the virus cannot be isolated, the diagnosis of poliomyelitis may be established serologically.  Serology tests may be performed by pairing patient's acute and convalescent [[serum|sera]], with neutralizing [[antibodies]], targeted to all three [[serotype]]s of the [[poliovirus|virus]].  However, [[serologic]] tests cannot distinguish between the "wild-type" and "vaccine-type"  polioviruses.<ref name="mand">{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Primary care]]
[[Category:Disease]]
[[Category:Infectious disease]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Disease]]

Latest revision as of 23:46, 29 July 2020

Polio Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Poliovirus

Differentiating Polio from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Polio laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polio laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polio laboratory findings

CDC on Polio laboratory findings

Polio laboratory findings in the news

Blogs on Polio laboratory findings

Directions to Hospitals Treating Polio

Risk calculators and risk factors for Polio laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Poliovirus may be isolated from pharyngeal secretions during the first week of the disease, and from feces during several weeks. Isolation of virus from the cerebrospinal fluid (CSF) is diagnostic, however this is rarely accomplished. Following isolation, the serotype and origin of the virus may be characterized by genomic sequencing. The CSF may show unspecific findings of aseptic meningitis, which are common to those found in infections by other viruses. When the virus cannot be isolated, serologic tests, using antibodies targeted to the 3 different serotypes may be used.[1][2]

Laboratory Findings

Viral Isolation

If poliovirus is isolated from a person with acute flaccid paralysis, or if it occurs in an area where there is low incidence of the disease, it must be further tested in order to assess the source of the virus. The virus may be "wild-type" (occurs naturally) or vaccine related (OPV).[1][2] The characterization of the source of the virus may be achieved by genomic sequencing.[3][2]

Cerebrospinal Fluid

In poliovirus infection, the CSF usually contains an increased number of white blood cells (10–200 cells/mm3, primarily lymphocytes) and mildly elevated protein (40–50 mg/100 mL).[1] However, these findings are similar to those of aseptic meningitis caused by other viruses.

The isolation of poliovirus from the CSF is particularly important in cases of paralytic poliomyelitis following administration of the vaccine. Since viral shedding in feces occurs during several weeks after the person has been vaccinated, isolation of the virus in the CNS, and its characterization as "wild-type" or "vaccine related", is the only way of proving an association between the disease and the vaccine.[2]

Serology

If the virus cannot be isolated, the diagnosis of poliomyelitis may be established serologically. Serology tests may be performed by pairing patient's acute and convalescent sera, with neutralizing antibodies, targeted to all three serotypes of the virus. However, serologic tests cannot distinguish between the "wild-type" and "vaccine-type" polioviruses.[2]

References

  1. 1.0 1.1 1.2 "Poliomyelitis".
  2. 2.0 2.1 2.2 2.3 2.4 Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  3. Kew, Olen M.; Mulders, Mick N.; Lipskaya, Galina Yu.; da Silva, Edson E.; Patlansch, Mark A. (1995). "Molecular epidemiology of polioviruses". Seminars in Virology. 6 (6): 401–414. doi:10.1016/S1044-5773(05)80017-4. ISSN 1044-5773.

Template:WH Template:WS